Synthesis and Pharmacological Evaluation of 4-(Aminomethyl) Containing Substituted Coumarin Derivatives as an Anti Inflammatory and Anti Cancer Agents

Abstract

Encouraged by the importance of the Coumarin derivative we have synthesized the series of the 4-(amino methyl) substituted Coumarin derivatives. Docking study of the synthesized compounds performed by using software SYBYL X 1.3 using surflex DOCK Module. Docking study carried out for predicts the activity as an anti cancer and anti inflammatory activity using the protein structure and compound docked on the allosteric site of the COX-2 and HER-1 receptor (PDB ID: 3W2S, 3NT1). By performing the docking study result found that the compound MDK-9, MDK-13 and MDK-14 having good docking score. The synthetic protocol for the target molecule initially Ethyl 4-bromo acetoacetate synthesized by the bromination reaction. In the second step by using the Ethyl 4-bromo acetoacetate and substituted hydroxyl benzene different substituted Coumarin derivatives prepared via pechmann reaction. In the final step using the substituted Coumarin derivatives and amino substituted compound final 4-(amino methyl) substituted coumarin derivatives prepared. The structure elucidation of the synthesized compound was carried out by the IR, MASS and Proton NMR. All the synthesized compounds were evaluated for anti-inflammatory and anticancer activity. Most of the compound shows the significant anti-inflammatory activity and anti cancer activity. Comparing to the Pharmacological activity and docking results, we conclude that 4- (amino methyl) containing substituted Coumarin derivatives seem to be potentially active drug.